Peripheral Neuropathy Treatment Market- Growth, Future Prospects, and Competitive Analysis, 2017 - 2025,

 Peripheral neuropathy treatment market - Growth, Future Prospects, and Competitive Analysis, 2017 - 2025,

 The global peripheral neuropathy treatment market was valued at US$ 1,470.9s Mn in 2016, and is expected to reach US$ 1,998.8 Mn by 2025, expanding at a CAGR of 3.2% from 2017 to 2025.



Market Insights

Peripheral neuropathy is caused by injury to peripheral nerves, which causes weakness, numbness, and tingling in the hands and feet. Traumatic injuries, infections, metabolic issues, genetic reasons, and exposure to toxins, as well as diabetes mellitus, are all causes of peripheral neuropathy. According to the World Health Organization (WHO), the world's diabetic population will reach 285 million by 2010. In the year 2030, this projection is expected to rise by 65 percent, to 438 million people. As a result of the increased prevalence of diabetes mellitus, the number of patients suffering from peripheral neuropathy is predicted to rise..Because there are only a few prescription medicines for neuropathic pain, off-label prescribing of various other pharmaceuticals is common. Due to the difficulty in identifying the most appropriate targets for inquiry, the pharmaceutical industry has been working to improve the already available treatment choices. For the treatment of neuropathic pain, there has been a recent shift toward the use of transdermal treatments.

 The global peripheral neuropathy treatment market is divided into two types of treatments: pharmacological and non-pharmacological. Pain relievers, anti-seizure medications, and antidepressants are examples of pharmacological treatments.. Transcutaneous electrical nerve stimulation, plasma exchange, and intravenous immune globulin are examples of non-pharmacological therapies (physical therapy and surgery). Non-pharmacological therapies are employed in conjunction with other treatment choices, while pharmacological therapies are the most often utilised and dominate the peripheral neuropathy market.

 North America was identified as the largest market for peripheral neuropathy in 2016. The primary driver of the North American peripheral neuropathy treatment market is the growing geriatric population and rising diabetes prevalence in the region. For the projection period 2017-2025, Asia Pacific is expected to be the fastest expanding market.

 Evaluation of Market Competition

 Abbott Laboratories, Bristol Myers Squibb, Cipla Limited, Eli Lilly and Company, GlaxoSmithKline plc, Lupin Limited, Merck and Co. Inc., Novartis, Pfizer Inc, and Dr. Reddy's Laboratories are some of the major competitors in the worldwide peripheral neuropathy market.

 

Comments

Post a Comment

Popular posts from this blog

Continuous Glucose Monitoring (CGM) Devices Market -Dynamics and Forecast

Image
CGM (Continuous Glucose Monitoring) technology allows you to monitor your glucose levels 24 hours a day using a sensor that delivers the data to a MiniMed insulin pump. However, these devices also aid in diabetes management by lowering individual insulin dosages. These gadgets' integrated software provides users with information about food consumption, medication, physical activity, and ailments.  As a result, an increasing number of diabetic patients are relying on these devices to control and treat their condition, propelling market growth. A growing number of continuous glucose monitoring devices are being integrated with apps and software to treat people with diabetes mellitus, thanks to the development of digital medicines.The rising prevalence of diabetes mellitus has boosted the market for continuous glucose monitoring (CGM) devices. The Continuous Glucose Monitoring (CGM) Market is estimated to develop at a CAGR of 14% over the forecast period. High blood glucose levels oc...
Read more

YOU YES YOU!

Image
Welcome to Riya's  blog! HEY Everyone! So this is my my very first blog and  i am quite excited about it. WELL  I am  a 21 years old girl who sees the world through her eyes just like everyone else. I believe each of us have their own views and opinions about every little thing that we see through our eyes wide open and that is  what individuality is ! Having our own brains , hobbies,rights,skills , gifts ,flaws and i certainly believe that embracing them is one of the best things a human could do. Okay well so the topic on what  i am going to throw a little  light on here is not self love or self respect or being righteous , strong or anything like that , My topic here is going to be "YOU"   . "YOU" can be anyone here including me 'YOU' = "Individual" Isn't it so weird that in a world having  millions and millions of people  with their own "IDENTITIES " still lack " INDIVIDUALITY ". You know why? because...
Read more

Key Benefits of Breath Analyzer Market

Image
The Breath Analyzer is a gadget that uses a breath sample to determine an individual's Blood Alcohol Content (BAC). The test is based on the link between the amount of alcohol in the blood and the amount of alcohol in the breath going through the lungs. The use of breath analyzer equipment has increased as the trend for severe alcohol intake has increased, resulting in traffic accidents.  Government actions that favor the market are also propelling it forward. Breathalyzer devices are also gaining popularity as a result of the growing demand for accurate BAC (blood alcohol content) levels at work, as well as their non-invasive nature, which is driving up demand for breath analyzer equipment. It's a must-have tool for keeping track of drugs, alcohol, TB, and asthma. and other diseases hence; it is projected that the demand for this system should constantly rise.  Inaccurate analysis, on the other hand, might lead to wrong diagnosis, which is the market's main constrai...
Read more